跳至主要内容
临床试验/IRCT20210101049905N2
IRCT20210101049905N2招募中2 期

Comparison between calcitriol and placebo on serum interleukin 6 level, stroke severity, infarct volume and clinical outcomes in patients with ischemic stroke

Hamedan University of Medical Sciences0 个研究点目标入组 78 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
78

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 85 years(—)
性别
All

入选标准

  • Age 18 to 85 years
  • Focal neurological disorder
  • Clinical diagnosis of acute ischemic stroke
  • Radiological findings of MRI and CT are consistent with the clinical diagnosis of acute hemisphere stroke
  • Patients who have been hospitalized for the first 24 hours after a stroke.
  • Patients suffering from ischemic stroke for the first time

排除标准

  • Evidence based on acute or chronic intracerebral hemorrhage and cerebral aneurysm
  • Existence of any etiology other than ischemia
  • Existence of any cognitive or behavioral disorders that lead to the patient not cooperating.
  • Consumption of any combination or drug with antioxidant effects except prescription drugs
  • Existence of another concomitant inflammatory disease
  • Taking medications other than standard ischemic stroke treatments that alter the levels of the factors under consideration.
  • Pregnancy and lactation
  • Use any combination with antioxidant and anti-inflammatory effects in the past month
  • Asthma and a history of anaphylactic shock
  • Taking drugs that interfere with calcitriol

研究者

相似试验

Effect of Clcitriol in Ischemi stroke | 临床试验